Results for tag: "Phase II Design"

The Phase II Design market is a subset of the Clinical Trials market, which focuses on the design and implementation of clinical trials during the second phase of drug development. This phase is typically used to assess the safety and efficacy of a drug or device in a larger population than the Phase I trials. It is also used to determine the optimal dose and to identify any potential side effects. The Phase II Design market is composed of a variety of stakeholders, including pharmaceutical companies, contract research organizations, and regulatory bodies. Companies in the Phase II Design market include QuintilesIMS, Parexel, ICON, PRA Health Sciences, and Syneos Health. Show Less Read more